España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Voya Infrastructure
IDE
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$10.55
-0.14
-1.31%
At close: -
$16.43
5.88
55.73%
After Hours: Feb 14, 6:55 AM EDT
Get Report
Comment
The dividend Ex-Date is in 10 days
Voya Infrastructure (IDE) Forecast
News
Earnings
Voya Infrastructure (IDE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Voya Infrastructure (NYSE:IDE) Stock
Voya Infrastructure Stock (NYSE: IDE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, October 07, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, July 05, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, July 01, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, May 11, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, May 06, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, June 16, 2021
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Tuesday, May 25, 2021
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Monday, May 24, 2021
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Thursday, May 20, 2021
Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights
Wednesday, March 31, 2021
Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights
Monday, March 01, 2021
Stocks That Hit 52-Week Highs On Monday
Benzinga Insights
Friday, February 26, 2021
Stocks That Hit 52-Week Highs On Friday
Benzinga Insights
Thursday, February 25, 2021
Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights
Tuesday, June 09, 2020
UPDATE: Ideanomics Says Total Value Of Autos ...
Benzinga Newsdesk
Monday, March 23, 2020
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Thursday, March 19, 2020
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Wednesday, March 18, 2020
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
Monday, March 16, 2020
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Thursday, March 12, 2020
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Friday, February 28, 2020
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Thursday, February 27, 2020
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Wednesday, December 19, 2018
Stocks Which Set New 52-Week Low Yesterday, T...
Benzinga Newsdesk
Monday, December 17, 2018
Stocks Which Set New 52-Week Low Last Trading...
Benzinga Newsdesk
Monday, October 29, 2018
Stocks Which Set New 52-Week Low Friday, Octo...
Benzinga Newsdesk
Wednesday, October 24, 2018
Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk
Friday, October 12, 2018
Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk
Thursday, October 11, 2018
Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk
Monday, June 16, 2014
CR Bard's Lutonix DCB Moves Closer To FDA Clearance - Analyst Blog
Benzinga
Thursday, June 05, 2014
ABIOMED Impella Platform Crosses 20K Mark - Analyst Blog
Benzinga
Tuesday, May 27, 2014
St. Jude Medical's PORTICO Trial Under Way - Analyst Blog
Benzinga
Wednesday, March 26, 2014
St. Jude Medical's Prodigy Neurostimulator Gets CE Mark - Analyst Blog
Benzinga
Monday, March 24, 2014
ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Benzinga
Friday, March 21, 2014
St. Jude Medical Initiates Nanostim Pacemaker Trial - Analyst Blog
Benzinga
Tuesday, December 20, 2011
Bard Acquires Lutonix for $225M
Benzinga
Wednesday, October 05, 2011
Biotech and Pharma Stock News; Aethlon Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation
Benzinga
